Eli Lilly & Co: Buy Rating Backed by Promising Orfoglipron Trials and Strong Pharmaceutical Pipeline
In a report released yesterday, Akash Tewari from Jefferies maintained a Buy rating on Eli Lilly & Co (LLY – Research Report), with a price ...
Argus Research Reaffirms Their Buy Rating on Eli Lilly & Co (LLY)
Argus Research analyst Jasper Hellweg maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) yesterday. The company’s shares ...
Zacks.com on MSN23h
Eli Lilly (LLY) Rises Higher Than Market: Key Facts
In the latest trading session, Eli Lilly (LLY) closed at $753.98, marking a +1.57% move from the previous day. This move outpaced the S&P 500's daily gain of 0.61%. Meanwhile, the Dow gained 0.3%, and ...
EA Stock Plunges 17%. Why the Videogame Maker Is Catching Downgrades.
Investors showed Electronic Arts stock a red card on Thursday after the videogame maker warned of slowing demand for its soccer-related titles. Shares in the Madden NFL publisher plummeted 17% to $117 ...
The Motley Fool20h
Best Travel Credit Cards
If you're on a Galaxy Fold, consider unfolding your phone or viewing it in full screen to best optimize your experience.